Correction to “Structure‐based pharmacophore modeling for precision inhibition of mutant ESR2 in breast cancer: A systematic computational approach”

Documents similaires

• Structure‐based pharmacophore modeling for precision inhibition of mutant ESR2 in breast cancer: A systematic computational approach
  par: Sirajul Islam, et autres
  Publié: (2024)
• Effects of web‐based interventions on quality of life among patients with breast cancer: A systematic review and meta‐analysis of randomized controlled trials
  par: Lorinda A. Coombs, et autres
  Publié: (2024)
• Correction to “Are embryonic stem cell markers and ALDH1A1 relevant in the context of breast cancer estrogen positivity”
  Publié: (2024)
• Prognostic implications of HER2NEU‐low in metastatic breast cancer
  par: Zachary Neubauer, et autres
  Publié: (2024)
• Machine learning‐based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results
  par: Meiying Yan, et autres
  Publié: (2024)